Manufacturing and Production

Showing 15 posts of 5792 posts found.

Is the pharmaceutical sector prepared to face a titanium dioxide ban?

May 19, 2023 Manufacturing and Production ACG, EMA, EU, Titanium Dioxide

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …
glsun-mall-9xmv81sz5fw-unsplash

Boehringer Ingelheim invests €350m in Europe’s largest biotech development centre

April 28, 2023 Manufacturing and Production

Boehringer Ingelheim (BI) have announced that it will invest €350m in a state-of-the-art Biologicals Development Centre (BDC) in Germany. It …

Trade union Unite calls for GSK staff walkouts over pay increase disputes

April 20, 2023 Manufacturing and Production

UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …
pawel-czerwinski-2y8ol_obs1i-unsplash_2

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

April 14, 2023 Manufacturing and Production

Pharma giant Eli Lilly’s Biologic Licence Application (BLA) for its bowel disease drug has been declined by the FDA over …

UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process

March 30, 2023 Manufacturing and Production

Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …

Eli Lilly invests $1bn in Limerick manufacturing facilities

March 28, 2023 Manufacturing and Production

Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …

Moderna chooses Oxfordshire for new UK facility

March 6, 2023 Manufacturing and Production

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …

REGENXBIO presents interim phase 2 data from drug developed on NAVXpressâ„¢ platform

February 13, 2023 Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …

US Department of Justice asks Third Circuit to reinstate conspiracy charges again KVK

February 8, 2023 Manufacturing and Production

The US Department of Justice (DoJ) encouraged the Third Circuit to reinstate ‘conspiracy to defraud’ charges against Philadelphia-based generic drug …

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023 Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023 Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

January 20, 2023 Manufacturing and Production

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of …

Johnson & Johnson scale back COVID-19 vaccination production

January 17, 2023 Manufacturing and Production

US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the …

$22m raised by PBS Biotech to expand single-use manufacturing products and services for cell therapy clients

January 9, 2023 Manufacturing and Production

PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider, has worked together with Avego Management and BroadOak …

Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval

January 9, 2023 Manufacturing and Production

Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …

Latest content